Corpus Intelligence IC Memo — METHODIST REHABILITATION HOSPITAL 2026-04-26 14:30 UTC
IC Memo — METHODIST REHABILITATION HOSPITAL
Investment Committee Memorandum | TX | 50 beds | Grade D | EBITDA uplift $2.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

METHODIST REHABILITATION HOSPITAL

CCN 673031 | DALLAS, TX | 50 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

METHODIST REHABILITATION HOSPITAL is a 50-bed community hospital in DALLAS, TX with $30.1M in net patient revenue and a 35.0% operating margin. The hospital serves a payer mix of 46.1% Medicare, 0.0% Medicaid, and 53.9% commercial.

Thesis: Turnaround. Our ML models identify $2.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 35.0% to 42.3% (+736bps).

Net Revenue HCRIS$30.1M
Current EBITDA COMPUTED$10.5M
Operating Margin COMPUTED35.0%
Occupancy HCRIS83.5%
Revenue / Bed COMPUTED$602K
Net-to-Gross HCRIS89.0%
Distress Probability MLnan%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
275
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 35.0% places it above the state median. Among 275 size-comparable peers (25-100 beds), the median margin is -3.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (25-100), prioritizing same-state peers. 275 hospitals in the comp set.

HospitalStateBedsRevenueMargin
METHODIST REHABILITATION HOSPI (Target)TX50$30.1M35.0%
DECATUR COMMUNITY HOSPITALTX81$361.0M-15.5%
WISE HEALTH SYSTEM - PARKWAYTX36$361.0M-15.5%
CHILDRENS MEDICAL CENTER OF PLTX72$336.7M20.9%
CORYELL MEMORIAL HOSPITALTX25$305.9M-1.5%
BAYLOR HEART AND VASCULAR HOSPTX53$255.0M30.0%
TEXAS ORTHOPEDIC HOSPITATX42$237.8M46.3%
PRESBYTERIAN HOSP FLOWER MOUNDTX99$215.0M28.3%
LAKE GRANBURY MEDICAL CENTERTX53$181.6M38.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$632K+210bp18mo
Cost to Collect4.5%2.5%$602K+200bp12mo
Denial Rate Reduction12.0%6.5%$596K+198bp12mo
A/R Days Reduction5200.0%3800.0%$366K+122bp9mo
Clean Claim Rate88.0%96.0%$19K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$632K
Cost to Collect
$602K
Denial Rate Reduction
$596K
A/R Days Reduction
$366K
Clean Claim Rate
$19K
Total EBITDA Uplift$2.2M
Current EBITDA$10.5M
+ RCM Uplift+$2.2M
Pro Forma EBITDA$12.7M
Current Margin35.0%
Pro Forma Margin42.3%
WC Released (1x)$1.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$16.2M$91.6M5.66x41.4%
Base (11x exit)10.0x11.0x$16.2M$106.0M6.55x45.6%
Bull Case9.0x11.0x$14.6M$118.5M8.14x52.1%
Bull (12x exit)9.0x12.0x$14.6M$133.6M9.17x55.8%
Bear Case11.0x10.0x$17.8M$75.2M4.22x33.4%
Bear (11x exit)11.0x11.0x$17.8M$88.5M4.97x37.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 275 hospitals with 25-100 beds
  • Same-state prioritization (n=276)
  • Comp margins: P25=-21.1% / P50=-3.4% / P75=10.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.